HPS Pharmacies wish to give notice that Dr Falk Pharma Australia, in consultation with the Therapeutic Goods Administration (TGA), has initiated a drug recall for Salofalk® Enema as follows:
Salofalk® Enema
Mesalazine 4 g/60 mL
ARTG 80652
The batches affected by this recall are:
- 230442A (Expiry: July 2025)
- 230443A (Expiry: July 2025)
- 230444A (Expiry: July 2025)
- 230445A (Expiry: July 2025)
This drug recall was initiated as bottles from the affected batches may contain a defect where the one-way valve in the applicator nozzle sometimes becomes stuck, preventing the administration of the enema liquid medicine.
Please inspect your stock and quarantine any defect stock. If HPS Pharmacies provide imprest management services to your facility, an HPS representative will inspect all stock stored in the designated imprest areas at the earliest opportunity. All affected products will be quarantined, and HPS Pharmacies will arrange for a credit as soon as possible. An HPS Pharmacies staff member will contact senior medical and nursing staff if there is an immediate impact to your facility.
Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Dr Falk Pharma Australia on 1800 373 255 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates